Kairos Pharma Ltd.
KAPA | AMEX
$1.75
-$0.04 (-2.23%)
Sep 22, 2026, 12:54 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -5.81M | -5.84M | -5.45M | -5.06M | -4.71M | -3.54M | -2.6M | -2.74M | -2.01M | -1.99M | -1.81M | -890K | -812K | -961K | -1.05M | -854K | -620K | -235K |
Depreciation & Amortization | 142K | 160K | 160K | 160K | 160K | 160K | 160K | 160K | 160K | 160K | 160K | 160K | 160K | 160K | 160K | 120K | 80K | 40K |
Stock-Based Compensation | 259K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -334K | -1.2M | -677K | -1.06M | -2.55M | -1.85M | -1.98M | -1.17M | 883K | 975K | 764K | 636K | 335K | 228K | 129K | 52K | n/a | -11K |
Other Non-Cash Items | 1.7M | 3.06M | 2.65M | 1.93M | 1.88M | 528K | 472K | 1.66M | 988K | 979K | 969K | 40K | 120K | 360K | 408K | 398K | 308K | 58K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -268K | -1.14M | -806K | -1.19M | -2.68M | -1.85M | -1.98M | -1.17M | 883K | 975K | 764K | 636K | 335K | 228K | 129K | 52K | n/a | -11K |
Operating Cash Flow | -3.97M | -3.76M | -3.44M | -4.16M | -5.34M | -4.71M | -3.96M | -2.09M | 25K | 125K | 81K | -54K | -197K | -213K | -353K | -284K | -232K | -148K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | 0 | 0 | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | 248K | -102K | n/a | n/a | -248K | 102K | n/a | n/a | n/a | 206K | 534K | 784K | 784K | 578K | 250K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.56M | 3.6M | 3.6M | 3.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10K | -10K | -10K | -10K |
Financial Cash Flow | 3.56M | 3.82M | 6.66M | 6.52M | 8.36M | 8.28M | 5.13M | 5.2M | -236K | -442K | -425K | -370K | 45K | 405K | 717K | 734K | 543K | 240K |
Net Cash Flow | -408K | 59K | 3.22M | 2.36M | 3.01M | 3.58M | 1.18M | 3.12M | -211K | -317K | -344K | 99K | 232K | 357K | 437K | n/a | n/a | n/a |
Free Cash Flow | -3.97M | -3.76M | -3.44M | -4.16M | -5.34M | -4.71M | -3.96M | -2.09M | 25K | 125K | 81K | -54K | -197K | -213K | -353K | -284K | -232K | -148K |
Adj. Free Cash Flow | -4.23M | -3.76M | -3.44M | -4.16M | -5.34M | -4.71M | -3.96M | -2.09M | 25K | 125K | 81K | -54K | -197K | -213K | -353K | -284K | -232K | -148K |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | 0 | 0 | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | 0 | 0 | n/a | n/a | n/a | n/a |
Owner Earnings | -3.97M | -3.76M | -3.44M | -4.16M | -5.34M | -4.71M | -3.96M | -2.09M | 25K | 125K | 81K | -54K | -197K | -213K | -353K | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove KAPA